お知らせ • Jul 14
Electromedical Technologies Files Form 15 Electromedical Technologies, Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common under the Securities Exchange Act of 1934, as amended. お知らせ • Apr 01
Electromedical Technologies, Inc. announced delayed annual 10-K filing On 03/31/2025, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. お知らせ • Nov 15
Electromedical Technologies, Inc. announced delayed 10-Q filing On 11/14/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • May 17
Electromedical Technologies, Inc. announced delayed 10-Q filing On 05/15/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Apr 04
Electromedical Technologies, Inc. announced delayed annual 10-K filing On 04/03/2024, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-K by the deadline required by the SEC. お知らせ • Nov 17
Electromedical Technologies, Inc. announced delayed 10-Q filing On 11/15/2023, Electromedical Technologies, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC. お知らせ • Jul 06
Electromedical Technologies, Inc. Announces the Resignation of Robert L. Hymers as an Independent Director Electromedical Technologies, Inc. announced that Robert L. Hymers, III resigned as an independent director of the Company, effective July 1, 2023. お知らせ • Feb 03
Electromedical Technologies, Inc. Appoints Robert L. Hymers, III as Independent Director and Member of the Compensation Committee Electromedical Technologies, Inc. announced that on February 1, 2023, effective January 1, 2023, the Company appointed Robert L. Hymers, III, age 39, as an independent director and member of the compensation committee of the Company for a term of six months. お知らせ • Dec 26
Electromedical Technologies, Inc. Announces Board Appointments On December 20, 2022, Electromedical Technologies, Inc. appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws. お知らせ • Dec 22
Electromedical Technologies, Inc. Announces Resignation of Lee Benson as an Independent Director On December 12, 2022, Lee Benson resigned as an independent director of the Company. There was a disagreement with the Company on its compensation policy disclosable under Item 5.02(a). お知らせ • Nov 01
Electromedical Technologies, Inc. Introduces the Wellnesspro Infinity™ Electromedical Technologies, Inc. introduced its new next-generation device, the WellnessPro Infinity™. The NEW WellnessPro Infinity™ device features: One compact device that encompasses ALL electrotherapy modalities. Can produce any frequency, any wave form (typical or atypical), any level of modulation; Designed to support: TENS, Microcurrent, IF, EMS, PEMF, CES, VNS, PNS, COLD Laser, POD Synchronization, IDNA™, Deep Pluse™, Cloud access and much more. Unprecedented accuracy. Easiest to use electrotherapy device on the market. New Doctor-Patient Portal for updates and personalized treatments. お知らせ • Jun 14
Electromedical Technologies, Inc. Appoints Lee Benson as an Independent Director On June 7, 2022, Electromedical Technologies, Inc. appointed Lee Benson, age 61, as an independent director of the Company. Mr. Benson began his career as the first employee in a small company providing specialty electroplating services to repair aircraft components. Mr. Benson purchased the company 1993. He then went on to found Able Engineering & Component Services in 1995 and Able Aerospace in 1999, subsequently expanding from 3 to 500+ employees and driving 15 straight years of 20% compounded average annual growth. After he secured the sale, Mr. Benson founded Execute to Win, LLC to help other businesses achieve maximum success and profit from his experience and expertise. ETW offers consultancy services to help businesses develop and implement effective communication strategies affecting decision making and approaches to work. お知らせ • Feb 17
Electromed, Inc., Appoints Christopher Holland as Chief Commercial Officer Electromed, Inc. announced the appointment of Christopher Holland as Chief Commercial Officer. Mr. Holland, an accomplished sales and marketing veteran, brings 30 years of experience in driving commercial growth in the Medical Technology market to Electromed. Prior to joining Electromed, Holland was the Vice President of Commercialization at Prosomnus Sleep Technologies, Inc. お知らせ • Jun 11
Electromedical Technologies Flagship Device to Be Introduced At National Chiropractic Expo Electromedical Technologies, Inc. announced that Director Kathy Strand R.N. will be hosting a booth and featuring the EMED flagship device at the upcoming Parker Seminars semi-annual national expo for chiropractors and chiropractic assistants In Orlando, Florida from June 11-13, 2021, including including the FDA cleared WellnessPro Plus. お知らせ • Dec 10
Electromedical Technologies, Inc. Announces Its New Strategic Partnership with WireBuzz, LLC Electromedical Technologies, Inc. announced its new strategic partnership with WireBuzz, LLC. The company elected to work with WireBuzz based upon its renowned reputation for content production, advanced marketing, and specifically, its impressive online customer conversion capabilities. In its first stage, WireBuzz is revamping the Company website to emulate the style and success of sites for WireBuzz Fortune 500 clients, and others. Future steps include the production of new marketing tools including video content for use by Electromedical Technologies’ distributors and influencers. WireBuzz produces more than 3,000 videos each year, which are extremely powerful and effective visual sales resources. The use of online content marketing is one of the most successful sales methods in the current COVID-19 environment and is expected to be a major driver of product sales, going forward. お知らせ • Jul 24
Electromedical Technologies, Inc. announced that it expects to receive $1 million in funding Electromedical Technologies, Inc. (OTCPK:ELCQ) announced an investment agreement for an aggregate gross proceeds of $1 million on July 23, 2020. The company will issue common shares in the transaction. The company will receive funding in three separate tranches.